Published in Blood Weekly, April 15th, 2004
According to researchers in South Korea, "[m]ajor ABO incompatibility may be potentially associated with immediate or delayed hemolysis and delayed onset of erythropoiesis in patients receiving allogeneic hematopoietic stem cell transplantation (HSCT)."
"To determine if hemolysis can be prevented by the inhibition of graft erythropoiesis," S.H. Park and coauthors at Sung Kyun Kwan University "performed hypertransfusion and assessed red cell transfusion requirement and independence."
"Between October 1995 and December 2001, 28 consecutive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.